adagrasib,cetuximab
mirati therapeutics,eli lilly
['rectal', 'crcsm', 'adagrasib', 'colorectal', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
for all my #colorectalcabcer folks! dr. pasi janne showed that in kras g12c the combination of adagrasib + cetuxmab was effective with a 46% response rate and with no added toxicity! #crcsm #kras #aacr23 #aacrssp 
#Cancer survivor, patient #advocate, Public #speaker, @AmericanCancer Director Project ECHO, @MDAndersonNews @SWOG volunteer. #crcsm #ayacsm Views my own